# Ireland exports to Germany: Trade Route Risk | Yugalinks

Understand reported exports from Ireland to Germany, the product routes that need a closer look, and the conditions that may affect planning.

Canonical: https://www.yugalinks.com/trade/corridor/IRL-DEU/risk

## Route overview

In 2024, Ireland reported $23.4B in goods exports to Germany. The overall review level is Critical attention.

## How to read this page

High attention means one or more conditions on these product types deserve a closer look. It is not a prediction that trade will stop or that a loss is certain. An HS6 code is the international six-digit code used to describe and compare traded goods.

## Key numbers

| Measure | Value | What it means |
| --- | ---: | --- |
| Latest reported exports | $23.4B | 2024 route total |
| Exports needing review | 44.8% | Share of route exports |
| Highest-priority products | 9 | Need the closest review |
| Products needing review | 96 | High-attention product types |
| Export volatility | 1.3 | Higher means bigger yearly swings |
| Below highest year | 34% | Compared with the route's best year |

## Product types to review

| Rank | HS6 | Product | Buyer-market imports | Below product high | Review level |
| ---: | --- | --- | ---: | ---: | --- |
| 1 | 300490 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $26.4B | 32.5% | Stable |
| 2 | 293499 | Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $5.8B | 0% | High attention |
| 3 | 293379 | Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | $4.2B | 63% | Critical attention |
| 4 | 300214 | Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $6.9B | 40.8% | Watch |
| 5 | 300215 | Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $14.9B | 0% | Stable |
| 6 | 382200 | Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $4.3B | 31.3% | Stable |
| 7 | 293339 | Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $1.6B | 66.4% | Critical attention |
| 8 | 293359 | Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $3.5B | 69.6% | Critical attention |
| 9 | 901819 | Medical, surgical instruments and appliances: electro-diagnostic apparatus (including apparatus for functional exploratory examination or for checking physiological parameters), n.e.s. in item no. 9018.1 | $2.1B | 22.7% | High attention |
| 10 | 330210 | Odoriferous substances and mixtures: of a kind used in the food or drink industries | $769.3M | 23.7% | High attention |

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-29). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.